Male Breast Growth – Side Effect from Risperdal
Risperdal is a medication manufactured by Johnson & Johnson to treat schizophrenia in adults and adolescents ages 13-17 years old. Risperdal is also prescribed to treat manic-depressive disorders, autism, Asperger’s syndrome, Tourette’s Snydrome, ADD, and paranoia. Risperdal has been approved by the FDA. See http://www.risperdal.com/risperdal/shared/pi/risperdal.pdf. This drug, however, is associated with a number of adverse health effects, including an alarming condition known as gynecomastia or male breast growth. The drug works by blocking dopamine, which releases prolactin from the pituitary gland. This, in turn creates a sedating effect on the patient. Some young boys who have taken Risperdal have suffered the humuliating effect of developing breasts. Risperal’s label does not provide consumers with appropriate warnings about the life changing effect of breast development, which necessarily requires corrective surgery. Some young boys who have taken Risperdal have suffered the humuliating effect of developing breasts. Examples of these incidents can be found at the following sites:
http://www.3news.co.nz/ADHD-drug-leads-to-breast-development-in-Kiwi-male/tabid/420/articleID/106534/cat/58/Default.aspx; http://tmap.wordpress.com/2009/05/26/risperdal/. If you or a love one have been diagnosed with gynecomastia following use of Risperdal, then contact our attorneys who can assist you with asserting your legal rights and seeking recovery for the injuries you have suffered.